Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in the French Healthcare Database
Clément Jambon-Barbara, Alex Hlavaty, Claire Bernardeau, Hélène Bouvaist, M. Chaumais, Marc Humbert, D. Montani, J. Cracowski, C. Khouri
{"title":"Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in the French Healthcare Database","authors":"Clément Jambon-Barbara, Alex Hlavaty, Claire Bernardeau, Hélène Bouvaist, M. Chaumais, Marc Humbert, D. Montani, J. Cracowski, C. Khouri","doi":"10.1183/23120541.00109-2024","DOIUrl":null,"url":null,"abstract":"Pulmonary arterial hypertension (PAH) is a rare and severe disease for which most of the evidence about prognostic factors, evolution and treatment efficacy comes from cohorts, registries and clinical trials. We therefore aimed to develop and validate a new PAH identification algorithm that can be used in the French healthcare database (SNDS).We developed and validated the algorithm using the Grenoble Alpes University Hospital medical charts. We first identified PAH patients following a previously validated algorithm (Gillmeyeret al. algorithm), using in hospital ICD-10 codes, right heart catheterisation procedure and PAH specific treatment dispensing. Then, we refined the latter with the exclusion of chronic thromboembolic pulmonary hypertension procedures and treatment, the main misclassification factor. Secondly, we validated this algorithm using a gold standard review of in-hospital medical charts and calculated sensitivity, specificity, positive and negative predictive value (PPV and NPV) and accuracy. Finally, we applied this algorithm in the French healthcare database and described the characteristics of the identified patients.In the Grenoble University Hospital, we identified 252 unique patients meeting all the algorithm's criteria between 01/01/2010 and 30/06/2022, and reviewed all medical records. The sensitivity, specificity, PPV, NPV and accuracy were 91.0%, 74.3%, 67.9%, 93.3% and 80.6% respectively. Application of this algorithm to the SNDS yielded the identification of 9931 patients with consistent characteristics compared to PAH registries.Overall, we propose a new PAH identification algorithm developed and adapted to the French specificities, that can be used in future studies using the French healthcare database.","PeriodicalId":4,"journal":{"name":"ACS Applied Energy Materials","volume":"13 5","pages":""},"PeriodicalIF":5.5000,"publicationDate":"2024-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Energy Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1183/23120541.00109-2024","RegionNum":3,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Pulmonary arterial hypertension (PAH) is a rare and severe disease for which most of the evidence about prognostic factors, evolution and treatment efficacy comes from cohorts, registries and clinical trials. We therefore aimed to develop and validate a new PAH identification algorithm that can be used in the French healthcare database (SNDS).We developed and validated the algorithm using the Grenoble Alpes University Hospital medical charts. We first identified PAH patients following a previously validated algorithm (Gillmeyeret al. algorithm), using in hospital ICD-10 codes, right heart catheterisation procedure and PAH specific treatment dispensing. Then, we refined the latter with the exclusion of chronic thromboembolic pulmonary hypertension procedures and treatment, the main misclassification factor. Secondly, we validated this algorithm using a gold standard review of in-hospital medical charts and calculated sensitivity, specificity, positive and negative predictive value (PPV and NPV) and accuracy. Finally, we applied this algorithm in the French healthcare database and described the characteristics of the identified patients.In the Grenoble University Hospital, we identified 252 unique patients meeting all the algorithm's criteria between 01/01/2010 and 30/06/2022, and reviewed all medical records. The sensitivity, specificity, PPV, NPV and accuracy were 91.0%, 74.3%, 67.9%, 93.3% and 80.6% respectively. Application of this algorithm to the SNDS yielded the identification of 9931 patients with consistent characteristics compared to PAH registries.Overall, we propose a new PAH identification algorithm developed and adapted to the French specificities, that can be used in future studies using the French healthcare database.
期刊介绍:
ACS Applied Energy Materials is an interdisciplinary journal publishing original research covering all aspects of materials, engineering, chemistry, physics and biology relevant to energy conversion and storage. The journal is devoted to reports of new and original experimental and theoretical research of an applied nature that integrate knowledge in the areas of materials, engineering, physics, bioscience, and chemistry into important energy applications.